Search results
Dr. Andrew Lieberman is the Gerald D. Abrams Professor in the Department of Pathology and Director of Neuropathology at the University of Michigan. Dr. Lieberman received his BS from Duke University and his MD and PhD from the University of Maryland Medical School.
- T32 Faculty Members
Dr. Andrew Lieberman’s research into neurological diseases...
- Publications
Andrew P. Lieberman Lab. About Us. Publications. 2022....
- T32 Faculty Members
- Roger L. Albin, MD
- Anthony Antonellis, Phd
- J. Chad Brenner, Phd
- Ronald Buckanovich, MD, Phd
- Thomas Carey, Phd
- Arul Chinnaiyan, MD, Phd
- Tomasz Cierpicki, Phd
- Nisha D'silva, Phd
- William Dauer, MD
- Mark Day, Phd
Professor of Neurology My primary research interest is in characterizing the pathogenesis and pathophysiology of neurodegenerative diseases. I’ve pursued these interests in both laboratory-based and clinical research using a variety of tools including analysis of human post-mortem specimens, extensive use of rodent models of disease, and extensive ...
Associate Professor of Human Genetics and Neurology Our overarching objective is to understand development and diseases of the peripheral nervous system, the latter including Charcot-Marie-Tooth (CMT) disease. CMT is a relatively common peripheral neuropathy that affects motor and sensory function in the extremities (feet, lower legs, and hands). T...
Assistant Professor of Otolaryngology-Head and Neck Surgery As the catalogue of driver-gene aberrations found in head and neck cancer is being rapidly established, my primary interest is to develop precision medicine paradigms for the most common genetic lesions found in the disease. My experience from the MiOncoSEQ precision medicine tumor board a...
Associate Professor of Internal Medicine and Obstetrics and Gynecology I consider myself a true translational scientist. I run a laboratory of 7-8 people. Our work focuses on potential means to improve ovarian cancer patient care. I have significant experience with research utilizing primary patient samples to study cell and molecular oncology. My ...
Professor of Otolaryngology-Head and Neck Surgery and Pharmacology Dr. Thomas Carey primary research focus is on basic and translational aspects of head and neck squamous cell carcinoma, with overall goal to improve the diagnosis, treatment and prevention of head and neck cancer. In particular this includes investigation of biomarkers of response t...
Professor of Pathology and Urology Arul M. Chinnaiyan, M.D., Ph.D. is a Howard Hughes Medical Institute Investigator, American Cancer Society Research Professor, and S.P. Hicks Endowed Professor of Pathology and Urology at the University of Michigan. He also serves as the inaugural Director of the Michigan Center for Translational Pathology (MCTP) ...
Associate Professor of Pathology and Biophysics My research is in structural biology of proteins involved in cancer and in chemical biology to develop small molecule inhibitors of oncogenic proteins. We are currently developing inhibitors of menin, Ash1L and Bmi1 proteins. My expertise is in structural biology, NMR spectroscopy and biophysical and ...
Professor of Oral Pathology and Dentistry, Associate Professor of Pathology Dr. D’Silva’s three major areas of professional activity are as a translational scientist in head and neck cancer, the clinical practice of pathology, and didactic teaching. Her research in head and neck cancer includes biomarkers for early detection and treatment resistanc...
Professor of Neurology and Cell and Developmental Biology I have longstanding experience and success in mentoring graduate and postdoctoral students in neuroscience research during the 14 years I have run my laboratory - the past 12 of which I have had continuous NIH support. The central focus of my laboratory is to dissect the cellular and circuit...
Professor of Urology Dr. Day's current research focuses on the tumor microenvironment and the translation of discoveries into the development of new therapeutic approaches to treat GU cancers. Dr. Day has been the PI of numerous sponsored projects from the NIH, the Department of Defense, American Cancer Society and numerous private foundations. His...
Research Interests. Study of the mechanisms of neurodegeneration in CAG/polyglutamine disorders and Niemann- Pick C using mouse and cellular models. Our goal is understand disease pathogenesis and define novel targets for treatment. Lab Website.
Dr. Andrew Lieberman is the Abrams Collegiate Professor of Pathology and Director of Neuropathology at the University of Michigan Medical School. He received his BS from Duke University and his MD, PhD from the University of Maryland Medical School.
Andrew Lieberman. Professor of Pathology, University of Michigan. Verified email at umich.edu. neuropathology. Title. Sort. Sort by citations Sort by year Sort by title. Cited by.
Jan 2, 2018 · #umichpath neuropathologist Andy Lieberman, MD, PhD is now serving a three-year term on the National Neuropathology Core Steering Committee of the National Alzheimer's Coordinating Center.
Andrew P. Lieberman Lab. About Us. Publications. 2022. Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease.
